| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.58 | 0.04 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.41 | 0.04 |